Bafna Pharmaceuticals Limited (BOM:532989)

Market Cap	9.51B +137.4%
Revenue (ttm)	1.43B -3.1%
Net Income	77.86M -5.8%
EPS	3.24 -7.0%
Shares Out	n/a
PE Ratio	122.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,386
Open	400.55
Previous Close	392.70
Day's Range	400.55 - 400.55
52-Week Range	95.00 - 400.55
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company offers its products in various dosage forms, including tablets, capsules, and solid orals. It provides various products for cardiovascular and hypertension, potent oncology, anti-infectives, central nervous system, and diabetic related diseases, as well as provision of contract research and manufacturing services. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, and Niger...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 339
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532989

Financial Performance

In fiscal year 2026, Bafna Pharmaceuticals's revenue was 1.51 billion, an increase of 3.26% compared to the previous year's 1.46 billion. Earnings were 111.00 million, an increase of 167.30%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 7, 2026

Data Sources Report a data error